Literature DB >> 17174628

MISSION!: optimization of acute and chronic care for patients with acute myocardial infarction.

Su-San Liem1, Barend L van der Hoeven, Pranobe V Oemrawsingh, Jeroen J Bax, Johanna G van der Bom, Jan Bosch, Eric P Viergever, Cees van Rees, Iman Padmos, Meredith I Sedney, Henk J van Exel, Harriette F Verwey, Douwe E Atsma, Enno T van der Velde, J Wouter Jukema, Ernst E van der Wall, Martin J Schalij.   

Abstract

BACKGROUND: Guideline implementation programs for patients with acute myocardial infarction (AMI) enhance adherence to evidence-based medicine (EBM) and improve clinical outcome. Although undertreatment of patients with AMI is well recognized in both acute and chronic phases of care, most implementation programs focus on acute and secondary prevention strategies during the index hospitalization phase only. HYPOTHESIS: Implementation of an all-phase integrated AMI care program maximizes EBM in daily practice and improves the care for patients with AMI. AIM: The objective of this study is to assess the effects of the MISSION! program on adherence to EBM for patients with AMI by the use of performance indicators.
DESIGN: The MISSION! protocol is based on the most recent American College of Cardiology/American Heart Association and European Society of Cardiology guidelines for patients with AMI. It contains a prehospital, inhospital, and outpatient clinical framework for decision making and treatment, up to 1 year after the index event. MISSION! concentrates on rapid AMI diagnosis and early reperfusion, followed by active lifestyle improvement and structured medical therapy. Because MISSION! covers both acute and chronic AMI phase, this design implies an intensive multidisciplinary collaboration among all regional health care providers.
CONCLUSION: Continuum of care for patients with AMI is warranted to take full advantage of EBM in day-to-day practice. This manuscript describes the rationale, design, and preliminary results of MISSION!, an all-phase integrated AMI care program.

Entities:  

Mesh:

Year:  2007        PMID: 17174628     DOI: 10.1016/j.ahj.2006.10.002

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  29 in total

1.  Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors:  J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  Left ventricular twist during dobutamine stress echocardiography after acute myocardial infarction: association with reverse remodeling.

Authors:  Emer Joyce; Darryl P Leong; Georgette E Hoogslag; Paul L van Herck; Philippe Debonnaire; Elena Abate; Eduard R Holman; Martin J Schalij; Jeroen J Bax; Victoria Delgado; Nina Ajmone Marsan
Journal:  Int J Cardiovasc Imaging       Date:  2013-12-19       Impact factor: 2.357

3.  Long-term medication adherence after myocardial infarction: experience of a community.

Authors:  Nilay D Shah; Shannon M Dunlay; Henry H Ting; Victor M Montori; Randal J Thomas; Amy E Wagie; Véronique L Roger
Journal:  Am J Med       Date:  2009-06-26       Impact factor: 4.965

4.  Association of long-term adherence to evidence-based combination drug therapy after acute myocardial infarction with all-cause mortality. A prospective cohort study based on claims data.

Authors:  Jutta Kuepper-Nybelen; Martin Hellmich; Sascha Abbas; Peter Ihle; Reinhard Griebenow; Ingrid Schubert
Journal:  Eur J Clin Pharmacol       Date:  2012-04-04       Impact factor: 2.953

5.  The 5352 A allele of the pro-inflammatory caspase-1 gene predicts late-acquired stent malapposition in STEMI patients treated with sirolimus stents.

Authors:  Sandrin C Bergheanu; Douwe Pons; Bas L van der Hoeven; Su-San Liem; Bob Siegerink; Martin J Schalij; Johanna G van der Bom; J Wouter Jukema
Journal:  Heart Vessels       Date:  2010-10-30       Impact factor: 2.037

6.  Standardised pre-hospital care of acute myocardial infarction patients: MISSION! guidelines applied in practice.

Authors:  J Z Atary; M de Visser; R van den Dijk; J Bosch; S S Liem; M L Antoni; M Bootsma; E P Viergever; C J Kirchhof; I Padmos; M I Sedney; H J van Exel; H F Verwey; D E Atsma; E E van der Wal; J W Jukema; M J Schalij
Journal:  Neth Heart J       Date:  2010-09       Impact factor: 2.380

7.  Prognostic implications of left ventricular regional function heterogeneity assessed with two-dimensional speckle tracking in patients with ST-segment elevation myocardial infarction and depressed left ventricular ejection fraction.

Authors:  Georgette E Hoogslag; Joep Thijssen; Ulas Höke; Helèn Boden; M Louisa Antoni; Philippe Debonnaire; Marlieke L A Haeck; Eduard R Holman; Jeroen J Bax; Nina Ajmone Marsan; Martin J Schalij; Victoria Delgado
Journal:  Heart Vessels       Date:  2013-09-27       Impact factor: 2.037

8.  Chronic Obstructive Pulmonary Disease and Risk of Atrial Arrhythmias After ST-Segment Elevation Myocardial Infarction.

Authors:  Laurien Goedemans; Rachid Abou; José M Montero-Cabezas; Nina Ajmone Marsan; Victoria Delgado; Jeroen J Bax
Journal:  J Atr Fibrillation       Date:  2020-12-31

9.  Designing and Governing Responsive Local Care Systems - Insights from a Scoping Review of Paramedics in Integrated Models of Care.

Authors:  Amir Allana; Walter Tavares; Andrew D Pinto; Kerry Kuluski
Journal:  Int J Integr Care       Date:  2022-04-13       Impact factor: 2.913

10.  The influence of residential distance on time to treatment in ST-elevation myocardial infarction patients.

Authors:  S Postma; J H E Dambrink; M J de Boer; A T M Gosselink; J P Ottervanger; P C Koopmans; J M Ten Berg; H Suryapranata; A W J van 't Hof
Journal:  Neth Heart J       Date:  2014-11       Impact factor: 2.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.